JACQUELYN L. SUMER - 21 Dec 2023 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role: Chief Legal Officer
Signature: /s/ Jacquelyn Sumer
Issuer symbol: CGEM
Transactions as of: 21 Dec 2023
Net transactions value: -$11,900
Form type: 4
Filing time: 22 Dec 2023, 17:30:13 UTC
Previous filing: 20 Dec 2023
Next filing: 23 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGEM	Common Stock	Sale	$11,900	-1,400	-3.1%	$8.50	44,133	21 Dec 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $8.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.49 to $8.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.